| Revenue growth | FY26 revenue stagnant at ₹1,713cr; Q4 revenue ₹519cr. |
|---|---|
| Margins | Sequential EBITDA margin improvement to 20.3% in Q4. |
| Order book | Order book intact; healthy RFP activity in CDMO segments. |
| Demand visibility | Improving demand trends in Pharma; Crop Protection seeing inventory normalization. |
| Management confidence | Cautiously optimistic but defensive regarding USFDA and previous guidance misses. |
Growth
FY26 revenue of ₹1,713cr shows long-term stagnation; Q4 EBITDA margins improved to 20.3% sequentially.
Outlook
Targeting 5-6 DMF filings annually; FY27 guidance deferred to Q1 results due to geopolitical uncertainty.
Risks
USFDA warning letter at Bangalore site; high raw material volatility; major asset impairment at Panoli.
Earnings Call filed with BSE, NSE: HIKAL. Summary written with AI assistance from the document.
Hikal Ltd: key numbers
- Share price
- ₹225.24
- Market cap
- ₹2,777 Cr
- Revenue (annual)
- ₹1,713 Cr
- Net profit (annual)
- ₹-48.80 Cr
- P/E (TTM)
- -82.2×Sector 47.3×
- Promoter holding
- 68.85%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hikal Ltd
All →Hikal Annual General Meeting
Hikal Ltd held its 38th AGM on September 23, 2026, approving financial statements, director appointments, remuneration revisions, and declaring a total dividend of ₹0.60 per share.
Hikal Production Started
Hikal has begun commercial production at its new cGMP Panoli facility, entering Personal Care manufacturing. First batches of UV filters and skincare ingredients are now being supplied to global customers.
Hikal Other Announcement
Hikal Ltd has filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations, 2015.
Hikal Annual Report
Hikal Limited has submitted its Annual Report for FY 2025-26 and the Notice of its 38th Annual General Meeting to the stock exchanges.
Hikal Annual General Meeting
Hikal Ltd has scheduled its 38th Annual General Meeting for September 23, 2026. The company fixed September 04, 2026, as the record date for final dividend eligibility.
Hikal Management Change
Hikal Limited has appointed Mr. Sameer Hiremath as Chairman and Managing Director for five years. The appointment is effective from October 1, 2026, subject to shareholder approval.
- Execution
- 5 years